MEDOF (Medios AG) Notes Receivable: $0 Mil (As of Mar. 2026)


MEDOF Medios AG MEDOF
88 GF Score
Price $50.00
GF Value $71.50
! 2 Warning Signs
View Full Analysis

What is Medios AG Notes Receivable?

Medios AG MEDOF 88 Notes Receivable is $0 Mil as of Mar. 2026. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $71.50. The stock has 2 warning signs investors should review.

Medios AG's Notes Receivable for the quarter that ended in Mar. 2026 was $0 Mil.

Medios AG Notes Receivable Historical Data

* Premium members only.

The historical data trend for Medios AG's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medios AG Notes Receivable Chart

Medios AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medios AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEDOF
88GF Score
Medios AG MEDOF
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medios AG Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0 Mil mean?
Medios AG (MEDOF) has a Notes Receivable of $0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medios AG and its competitors.
Is Medios AG's Notes Receivable too high?
Medios AG's current Notes Receivable is $0 Mil. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's Notes Receivable compare to MCK and COR?
Medios AG's Notes Receivable of $0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Distribution company?
A good Notes Receivable depends on the Medical Distribution industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medios AG and its competitors. Medios AG's current Notes Receivable is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current Notes Receivable of $0 Mil. The stock's GF Value™ is $71.50, compared to a current price of $50.00 — trading 30.1% below its estimated fair value. The current Notes Receivable is $0 Mil. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Medios AG (MEDOF), the current Notes Receivable is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medios AG (MEDOF) Overvalued in 2026?

Based on GuruFocus' analysis, Medios AG stock appears to be undervalued. The current stock price of $50.00 is trading 30.1% below its estimated GF Value™ of $71.50.

Key valuation signals for MEDOF:

  • Notes Receivable: $0 Mil
  • GF Value™: $71.50 vs. price of $50.00 (30.1% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medios AG Business Description

Address Heidestrasse 9, Berlin, DEU, 10557
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score

Get the complete analysis for MEDOF

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$50.00
Price
$71.50
GF Value